Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

133 results
  1. ... syndrome, however, the result was not statistically significant. Additional studies have demonstrated similar survival outcomes ... that develop via the MSI pathway have more ...
  2. ... lOInlverslte Laval / edited by Marcel Martin, Louis Dlonne. - New York : Stratton Intercontinental Medical Book Corp., c!976. Ix, 182 p. : 111.-- (Symposia specialists medical books) 1. Immunotherapy - congresses 2. Neoplasms - therapy - congresses 3. Neoplasms - Immunology - congresses I. Dlonne, Louis, ...
  3. ... often with adjuvant intravesical therapy to destroy residual tumor cells using chemotherapeutic agents (e.g., ... Fatigue Syndrome Pacific Northwest ...
  4. ... abdominoperineal resection. Alternatively, patients may be treated with ... for patients with early-stage tumors smaller than 1 cm. It is also unclear ...
  5. ... the hypothesis that anaplasia evolves as a late event from a subpopulation of Wilms ... with responsiveness to therapy rather than to tumor aggressiveness. It is most ...
  6. ... efficacy of Iscador as an adjuvant long-term treatment after surgery for ... the use of immunotherapy was more frequent in the control group. Only ...
  7. NLM Digital Collections - Targeted immune modulators for rheumatoid arthritis: effectiveness & value : evidence report 
    Publication: Boston, MA : Institute for Clinical and Economic Review, March 10, 2017
    ... 1) 0* patient who received rescue 2) 0 ... rate, Deaths (Trial Name) van Vollenhoven RF The New 1) PBO+MTX (n=106) Neoplasm benign, Serious infections, n (%) Discontinuation due to AEs, ...
  8. ... New drug regimens. Surgical resection of the primary tumor. New radiation therapy schedules and techniques (e.g., timing, three-dimensional ... review showed that 43% of patients treated with additional chemotherapy at the ... tumor have achieved successful palliation with endobronchial laser therapy ( ...
  9. ... reporting a significant benefit, with patients receiving the additional maintenance therapy having an increased event free ( Le Gouill et al. , 2014 ) and progression ...
  10. NLM Digital Collections - Hematologic malignancies : regulatory considerations for use of minimal residual disease in ... 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2020
    ... Topic Drug Approval Drug Development Drugs, Investigational Hematologic Neoplasms -- drug therapy Investigational New Drug Application Neoplasm, Residual Endpoint Determination Leukemia, Lymphocytic, ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last